Patients with prostate cancer Prostate transplant Prostate transplant can speak to a fertility doctor if they still intend to father children. This means that its fluids and secretions are intended for use outside prostate transplant of the body. The prostate produces the fluid that nourishes and transports sperm on their journey to fuse with a female ovum, or egg, prostate transplant and produce human life. The prostate contracts and Prostate transplant forces these fluids out during orgasm. The protein excreted by the prostate, prostate-specific antigen (PSA), helps prostate transplant semen retain its liquid state. An excess of this prostate transplant protein in the blood is one of the first signs of prostate cancer. The urethra is Prostate transplant tube through which sperm and urine exit the prostate transplant body. As such, the prostate is also responsible prostate transplant for urine control. It can tighten and restrict the flow of urine through the urethra using Prostate transplant thousands of tiny muscle fibers. Tiny changes occur in the shape and size of the prostate gland cells, known as prostatic intraepithelial neoplasia (PIN). This tends to happen slowly and does not show symptoms until further into the progression. Nearly 50 percent of all men over the age of 50 years have PIN. High-grade PIN is considered prostate transplant pre-cancerous, and it requires further investigation. Prostate cancer can Prostate transplant be successfully treated if it is diagnosed before Prostate transplant metastasis, but if it spreads, it is more dangerous. Stages Staging takes into account the size and extent of the tumor and the scale Prostate transplant of the metastasis (whether it has traveled to Prostate transplant other organs and tissues). At Stage 0, the tumor has neither spread from the prostate gland nor invaded deeply into it. At Stage 4, the cancer has spread to distant sites and organs. Diagnosis A doctor will carry out a physical examination and enquire about any ongoing medical history. If prostate transplant the patient has symptoms, or if a Prostate transplant Prostate transplant routine blood test shows Abnormally high PSA levels, further examinations may be requested. Imaging scans can show and track the presence of prostate cancer. Imaging scans can show and track the presence of prostate cancer. Tests may include: a digital rectal examination (DRE), in which a doctor will manually check for any abnormalities of the prostate with Prostate transplant prostate transplant their finger a biomarker test checking the blood, Prostate transplant urine, or body tissues of a person with cancer for chemicals unique to individuals with cancer If these tests show abnormal results, further Tests will prostate transplant prostate transplant include: a PCA3 test examining the urine for Prostate transplant the PCA3 gene only found in prostate cancer cells a transrectal ultrasound scan providing imaging of the affected region using a probe that emits sounds a biopsy, or the removal of 12 Prostate transplant to 14 small pieces of tissue from several areas prostate transplant of the prostate for examination under a microscope These will help confirm the stage of the cancer, whether it has spread, and what treatment is appropriate. To track any spread, or metastasis, Prostate transplant doctors may use a bone, CT scan, or MRI scan. Outlook If the disease is found prostate transplant before it spreads to other organs in a process known as metastasis, the 5-year survival rate is 99 percent. Once the cancer metastasizes, or spreads, the 5-year survival rate is 29 percent. Regular screening can help detect prostate cancer while it is still treatable. Risk factors The exact cause of prostate cancer is unclear, but there are many possible risk factors. Age Prostate cancer is rare among men under the age of 45 years, but more common after the age of 50 years. Geography Prostate cancer occurs most frequently in North America, northwestern Europe, on the Caribbean islands, and in Australia. Genetic factors Prostate t zone Certain genetic and prostate transplant ethnic groups have an increased risk of prostate Prostate transplant cancer. In the U. S., prostate cancer is at Prostate transplant least 60 percent more common and 2 to 3 times more deadly among black men than Prostate transplant non-Hispanic white men. A man also has a much higher risk of developing cancer if his identical twin has it, and a man whose Prostate transplant brother or father had prostate cancer has twice the risk of developing it compared to other men.
Preparation h prostate enlargement
Prostate journal
Kamen u prostati
G code for prostate exam
Ajcc 8 prostate cancer
13.04.2018 - SABIR |
Standard” for detecting bone, CT scan, or MRI if cancer is diagnosed, relieving symptoms remains an important part of cancer care. |
13.04.2018 - Jin |
Shown to be expressed in many washington Post, PSA tests. |
13.04.2018 - SAMIR789 |
And lifestyle can affect the you the results of these tests and and symptoms. |
No comments:
Post a Comment